Search

everythinglearnresearchcommunity

for

Search:↓

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Androgens can cause hair growth in some areas but hair loss on the scalp.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Androgens can both increase body hair and cause scalp hair loss.

The new test can measure very small amounts of testosterone in hair, and grinding the hair up first gives more accurate results.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

The Wnt/β-catenin pathway is important for body functions and diseases, and targeting it may treat conditions like cancer, but with safety challenges.

HSPGs help control stem cell behavior, affecting hair growth and offering a target for hair loss treatments.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

Pubic hair transplant surgery is an effective and permanent treatment for pubic hair loss.

Hair transplant surgery is a good cosmetic solution for people with little or no pubic hair, especially to boost their self-esteem.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Collecting hair for cortisol analysis is possible in low-income mother-toddler pairs.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Hair graying is influenced by factors like nerves, fat cells, and immune cells, not just hair follicles.

Aging men face unique health issues like erectile dysfunction, prostate problems, and baldness.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Scalp hair grows at 0.37 mm/day, forearm hair at 0.18 mm/day, and thigh hair at 0.30 mm/day, with no significant differences found in people with certain hair conditions.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.